Aired April 23: Empiric antibiotic choices for community acquired pnuemonia and clindamycin versus trimethoprim-sulfamethoxazole for skin and soft tissue infections.
Fahad and Amol want you to understand the following:
1. A large, high quality RCT showed that there was no significant difference between an empiric treatment strategy of beta-lactam vs beta-lactam plus macrolide vs respiratory fluoroquinolone for the treatment of community-acquired pneumonia requiring hospitalization in a non-ICU setting.
2. A high quality RCT showed that there was no significant difference between clindamycin and TMP-SMX, with respect to either efficacy or side-effect profile, for the treatment of uncomplicated skin infections in regions with endemic Methicillin-Resistant Staphylococcus Aureus.
The papers
DF Postma et al. Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults. N Engl J Med. 2015 Apr 2;372(14):1312-23. (PubMed).
LG Miller et al. Clindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin Infections. N Engl J Med. 2015 Mar 19;372(12):1093-103. (PubMed).
Good stuff
Anglo-Saxon remedy kills hospital superbug MRSA. Clare Wilson. New Scientist. 30 Mar 2015.
Genetically Determined Height and Coronary Artery Disease.
